Search Results - "Arnautou, Pierre"

Mesenchymal stromal cells confer chemoresistance to myeloid leukemia blasts through Side Population functionality and ABC transporter activation by Boutin, Laetitia, Arnautou, Pierre, Trignol, Aurélie, Ségot, Amandine, Farge, Thomas, Desterke, Christophe, Soave, Sabrina, Clay, Denis, Raffoux, Emmanuel, Sarry, Jean-Emmanuel, Malfuson, Jean-Valère, Lataillade, Jean-Jacques, Le Bousse-Kerdilès, Marie-Caroline, Anginot, Adrienne

“…Targeting chemoresistant malignant cells is one of the current major challenges in oncology. Therefore, it is mandatory to refine the characteristics of these…”
Get full text

Effective use of intensive treatment against multiple myeloma of recipient origin after allogeneic transplantation for acute myeloid leukemia by de Charry, Félicité, Konopacki, Johanna, Bugier, Sarah, Foissaud, Vincent, Sloma, Ivan, Malfuson, Jean-Valère, Arnautou, Pierre

“…We describe here a 56-years –old woman cured in our institution for an acute myeloid leukemia (AML) and a monoclonal gammopathy of undetermined significance…”
Get full text

Management of acute radiation syndrome by Arnautou, Pierre, Garnier, Guillaume, Maillot, Jean, Konopacki, Johanna, Brachet, Michel, Bonnin, Annabelle, Amabile, Jean-Christophe, Malfuson, Jean-Valère

“…[Display omitted] Acute radiation syndrome encompasses a spectrum of pathological manifestations resulting from exposure to high doses of ionizing radiation…”
Get full text

Leukaemic evolution of rare donor CSF3R germline mutation after umbilical cord blood transplant by Arnautou, Pierre, Quang, Violaine Tran, Konopacki, Johanna, Chevillon, Florian, Bories, Dominique, Sloma, Ivan, Malfuson, Jean‐Valère

Get full text

Real-world study of the efficacy and safety of belantamab mafodotin (GSK2857916) in relapsed or refractory multiple myeloma based on data from the nominative ATU in France: IFM 2020-04 study by Talbot, Alexis, Bobin, Arthur, Tabone, Léa, Lambert, Jérôme, Boccaccio, Catherine, Deal, Cécile, Petillon, Marie-Odile, Allangba, Olivier, Agape, Philippe, Arnautou, Pierre, Belkhir, Rakiba, Cailleres, Sylvie, Chaoui, Driss, Chrétien, Marie-Lorraine, Decaux, Olivier, Schulmann, Samantha, Frenzel, Laurent, Gastaud, Lauris, Huart, Antoine, Hulin, Cyrille, Karlin, Lionel, Laribi, Kamel, Le Calloch, Ronan, Lenain, Pascal, Macro, Margaret, Manier, Salomon, Montes, Lydia, Moreau, Stéphane, Moreau, Philippe, Morel, Véronique, Norwood, James, Piocelle, Frédérique Orsini, Perrot, Aurore, Pica, Gian Matteo, Rey, Philippe, Schmitt, Anna, Stoppa, Anne-Marie, Tiab, Mourad, Touzeau, Cyrille, Vidal, Valérie, Vignon, Marguerite, Vincent, Laure, Van De Wyngaert, Zoé, Zarnitsky, Charles, Kerbouche, Naima, Paka, Prani, Leleu, Xavier, Arnulf, Bertrand, Avet-Loiseau, Hervé

“…Belantamab mafodotin (BM) is an anti-BCMA antibody-drug conjugate (GSK2857916) that represents an alternative option in multiple myeloma. We sought to assess…”
Get full text

Autoimmune hypoglycemia expands the biological spectrum of HHV8+ multicentric Castleman disease by Arnautou, Pierre, Auclair, Martine, Fellahi, Soraya, Bouché, Clara, Fieschi, Claire, Barrak, Elias, Queyrel-Moranne, Viviane, Chaillous, Lucy, Blin, Nicolas, Malphettes, Marion, Fadlallah, Jehane, Bertinchamp, Remi, Gérard, Laurence, Bengoufa, Djaouida, Galicier, Lionel, Oksenhendler, Eric, Vigouroux, Corinne, Boutboul, David

“…•Autoimmune hypoglycemia belongs to the clinical spectrum of HHV8+ MCD and rituximab is an effective treatment of this condition.•This rare complication is…”
Get full text

Effective use of intensive treatment against multiple myeloma of recipient origin after allogeneic transplantation for acute myeloid leukemia by de Charry, Félicité, Konopacki, Johanna, Bugier, Sarah, Foissaud, Vincent, Sloma, Ivan, Malfuson, Jean-Valère, Arnautou, Pierre

Get full text